Skip to content
healthcare.dev

LISDEXAMFETAMINE DIMESYLATE

NDC 31722-321, lisdexamfetamine dimesylate, tablet, chewable, from Camber Pharmaceuticals, Inc..

Product NDC
31722-321
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217068
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-321 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISDEXAMFETAMINE DIMESYLATE10 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
31722-321-0131722032101100 TABLET, CHEWABLE in 1 BOTTLE (31722-321-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f05bac63-08a5-49ce-8180-b33b76c0c0c4
  • NADAC price for package 31722032101

    GET /v1/drugs/nadac/31722032101

Use it

Look up 31722-321 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-321 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-321. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.